MedPath
FDA Approval

Terbutaline Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
UBI Pharma Inc.
DUNS: 658871159
Effective Date
February 15, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbutaline(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

UBI Pharma Inc.

UBI Pharma Inc.

658871159

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbutaline Sulfate

Product Details

NDC Product Code
72843-101
Application Number
ANDA200122
Marketing Category
ANDA (C73584)
Route of Administration
SUBCUTANEOUS
Effective Date
February 15, 2019
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Code: 576PU70Y8EClass: ACTIBQuantity: 1 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath